I agree that this site is using cookies. You can find further informations here.
X
Hassenpflug, Peter
19  results:
OpenAccess-fulltext X
Search for persons X
?
1

CoMICS II - Ein event-orientiertes Mikrosimulationssystem:

Busch, Carsten ; Hassenpflug, Peter
https://uko.opus.hbz-nrw.de/frontdoor/index/index/docId/253.  , 2008
Link: https://uko.opus.hbz-nrw..
 
?
2

High-Dose Treosulfan and Melphalan as Consolidation Therapy..:

Koch, Raphael ; Gelderblom, Hans ; Haveman, Lianne...
boreal:263599.  , 2022
Link: http://hdl.handle.net/20..
 
?
3

High-Dose Treosulfan and Melphalan as Consolidation Therapy..:

Koch, Raphael ; Gelderblom, Hans ; Haveman, Lianne...
boreal:263599.  , 2022
Link: http://hdl.handle.net/20..
 
?
4

High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescu..:

Whelan, Jeremy ; Le Deley, Marie-Cecile ; Dirksen, Uta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209090/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
5

A CXCR4-Targeted Site-Specific Antibody-Drug Conjugate**:

Kularatne, Sumith A ; Deshmukh, Vishal ; Ma, Jennifer...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331128/.  , 2014
Link: http://www.ncbi.nlm.nih...
 
?
6

Supplementary Figure S2 from Zoledronic Acid Add-on Therapy..:

Raphael Koch ; Lianne Haveman ; Ruth Ladenstein...
doi:10.1158/1078-0432.24825960.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
7

Supplementary Table S3 from Zoledronic Acid Add-on Therapy ..:

Raphael Koch ; Lianne Haveman ; Ruth Ladenstein...
doi:10.1158/1078-0432.24825942.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
8

Supplementary Data S2 from Zoledronic Acid Add-on Therapy f..:

Raphael Koch ; Lianne Haveman ; Ruth Ladenstein...
doi:10.1158/1078-0432.24825969.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
9

Supplementary Data S1 from Zoledronic Acid Add-on Therapy f..:

Raphael Koch ; Lianne Haveman ; Ruth Ladenstein...
doi:10.1158/1078-0432.24825972.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
10

Supplementary Figure S4 from Zoledronic Acid Add-on Therapy..:

Raphael Koch ; Lianne Haveman ; Ruth Ladenstein...
doi:10.1158/1078-0432.24825954.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
11

Supplementary Figure S3 from Zoledronic Acid Add-on Therapy..:

Raphael Koch ; Lianne Haveman ; Ruth Ladenstein...
doi:10.1158/1078-0432.24825957.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
12

Supplementary Table S1 from Zoledronic Acid Add-on Therapy ..:

Raphael Koch ; Lianne Haveman ; Ruth Ladenstein...
doi:10.1158/1078-0432.24825948.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
13

Supplementary Table S5 from Zoledronic Acid Add-on Therapy ..:

Raphael Koch ; Lianne Haveman ; Ruth Ladenstein...
doi:10.1158/1078-0432.24825936.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
14

Supplementary Figure S1 from Zoledronic Acid Add-on Therapy..:

Raphael Koch ; Lianne Haveman ; Ruth Ladenstein...
doi:10.1158/1078-0432.24825966.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
15

Supplementary Table S4 from Zoledronic Acid Add-on Therapy ..:

Raphael Koch ; Lianne Haveman ; Ruth Ladenstein...
doi:10.1158/1078-0432.24825939.v1.  , 2023
Link: https://doi.org/10.1158/..
 
1-15